Microfluidic Ferrofluid Cell Separation for Antigen Capacity Profiling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack the capability to simultaneously sort target cells based on specific surface antigen levels and profile antigen-binding capacity distribution effectively.
Innovation Solution
A microfluidic device and system utilizing ferrohydrodynamic principles for cell separation, involving magnetically labeled cell-bead complexes and a series of collection stages with controlled magnetic fields and buffer fluid dilution to quantify and isolate target cells based on their antigen-binding capacity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional sorting methods are used to separate target cells based on surface antigen levels, then cell separation can be achieved, but the capability to simultaneously profile antigen-binding capacity distribution is lost
Solution Approach 1:
The patent combines cell sorting and antigen-binding capacity profiling into a single integrated microfluidic device. The device simultaneously performs magnetic labeling-based separation and quantitative measurement of antigen-binding capacity distribution, eliminating the need for separate sorting and profiling instruments while achieving both functions in one system.
Solution Approach 2:
The microfluidic device is designed with multi-functionality, serving both as a cell separator and an antigen-binding capacity analyzer. The same device structure and magnetic field system are used for both sorting cells by surface antigen levels and profiling the distribution of antigen-binding capacities, making the system universally applicable for both tasks.
2Productivity
If magnetic labeling is used to increase cellular magnetic content for better separation, then separation efficiency improves, but the relationship between magnetic content and antigen-binding capacity must be maintained
Solution Approach 1:
The patent utilizes parameter changes by varying the concentration of magnetic beads in the labeling solution and adjusting the incubation conditions to optimize the number of beads bound per cell. This controlled parameter adjustment ensures sufficient magnetic content for efficient separation while maintaining the proportional relationship between magnetic content and antigen-binding capacity for accurate quantification.
Solution Approach 2:
The device incorporates real-time measurement capabilities that provide feedback on the magnetic content of labeled cells. This feedback mechanism allows for optimization of the labeling process, ensuring that cells acquire sufficient magnetic content for separation while maintaining the quantitative relationship needed for antigen-binding capacity profiling.
3Manufacturing precision
If multiple collection stages are added to isolate different cell populations, then isolation precision improves, but device complexity and processing time increase
Solution Approach 1:
The device divides the cell separation process into multiple sequential collection stages, each targeting a specific range of antigen-binding capacities. This segmentation allows different cell populations to be isolated in distinct chambers simultaneously, achieving high isolation precision without requiring sequential processing that would increase time loss.
Solution Approach 2:
The patent transitions from sequential one-dimensional processing to parallel multi-dimensional separation. Multiple collection stages operate simultaneously in different spatial locations within the microfluidic device, allowing concurrent isolation of different cell populations. This dimensional expansion enables precise isolation of multiple cell types at the same time rather than in sequence.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise quantification and isolation of target cells, including rare cells, by correlating cellular magnetic content with antigen-binding capacity, enhancing understanding and treatment of diseases.
Implementation Method 1
providing a magnetically labeled biological sample comprising a plurality of cell-bead complexes, individual ones of the cell-bead complexes comprising a target cell bound to one or more antibody-conjugated magnetic beads
Implementation Method 2
a target cell bound to one or more antibody-conjugated magnetic beads
Implementation Method 3
combining the magnetically labeled biological sample with a colloidally stable ferrofluid to produce a mixed ferrofluid biological sample
Implementation Method 4
one or more magnetic sources are adjacent to the cell collection section and configured to produce a substantially non-uniform magnetic field such that, for each individual collection stage, one or more cell-bead complexes having cellular magnetic content greater than the ferrofluid concentration within the individual collection stage are captured
Implementation Method 5
diluting the ferrofluid concentration of the mixed ferrofluid biological sample with a buffer solution for a subsequent collection stage
Data Source
AI summary
In various aspects, microfluidic devices, systems, kits, and methods of using quantitative ferrohydrodynamic cell separation devices are provided for quantifying antigen-binding capacity and isolating target cells. The method includes providing a magnetically labeled biological sample cell-bead complexes comprising a target cell bound to antibody-conjugated magnetic beads and combining the magnetically labeled biological sample with a colloidally stable. Flowing the mixed ferrofluid biological sample through a microfluidic device comprising a plurality of collection stages arranged in series and fluidly connected. Collecting a first portion of cell-bead complexes having the cellular magnetic content greater than the ferrofluid concentration of the mixed ferrofluid biological sample. Diluting the ferrofluid concentration of the mixed ferrofluid biological sample with a buffer solution for a subsequent collection stage. Collecting, in a subsequent collection chamber, another portion of cell-bead complexes having the cellular magnetic content greater than the ferrofluid concentration in the subsequent collection stage.